Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Deal-signing at the German cloud computing and software giant SAP turned cautious in the second quarter, CFO Dominik Asam told CNBC.

Buynetmeds.com has been sent a warning letter over the sale of opoioids and weight-loss drugs without a prescription.

GreensKeeper stays cautious amid frothy markets, betting on long-term value. Learn how disciplined investing can thrive when ...